
Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…

Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…
Founded: 2023
Headquarters: Villejuif, Île-de-France, France
Focus: AI-powered precision oncology platform for drug development
Flagship products: O-Predict; O-Validate
Notable funding: Seed round (Dec 2024); ~€11M–€15M total raised
28 employees
Cancer drug development, with an emphasis on colorectal and pancreatic cancers
2023
Biotechnology Research
≈€11,000,000
Seed round announced Dec 3, 2024; reporting cites nondilutive support from Bpifrance and total capital raised to date near €15M in some sources.
“Bpifrance; Singular; additional investors recorded (Amazon Web Services, HCVC, SistaFund, Speedinvest, Verve Ventures)”
We are looking for a motivated intern to quantify and characterize the genomic, transcriptomic, and functional drift of PDOs over time. You will:
You will work closely with both the and teams and leverage across multiple passages and PDO lines. This internship is a strong opportunity to contribute to in a highly multidisciplinary environment.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,800+
New This Week
| Company |
|---|
Explore and curate existing multi-omics and functional datasets for PDOs across passages.
Design and implement drift metrics at genomic, transcriptomic, and functional levels.
Perform statistical analyses and data visualization (clustering, dimensionality reduction, trajectory-like analyses, correlation with growth/response).
Present results regularly to the computational biology and wet lab teams.
Document your code and analyses so they can be reused by the team.Needs to have
BSc, MSc, MEng or any related diploma in the field of computational biology, computer science or machine learning
Strong quantitative background and prior experience in computational biology and/or machine learning
Genuine curiosity and energy to explore new projects
Exceptional collaboration and communication skills
Proficiency in English
Nice-to-Haves
Technical Interview (45 minutes call) – A deep dive into your technical skills and expertise relevant to the role.
Founder Interview: As final step of our recruitment process, you will meet the CTO of Orakl Oncology in person at our office. This meeting is an opportunity for the founders to assess cultural fit and ensure alignment with our company values.